Learn about an investigational clinical research study
The ADVANCE-PD Study
The ADVANCE-PD study is a Phase III clinical trial evaluating the safety and efficacy of an investigational drug in subjects with advanced Parkinson’s Disease (PD).
Participants must:
- Have been at least 30 years old at the time of PD diagnosis
- Be taking carbidopa-levodopa (e.g. SINEMET®)
Study Information:
If you are eligible and choose to participate in the ADVANCE-PD Study, you will receive IPX066. IPX066 is an investigational form of a currently marketed oral medication for Parkinson’s Disease. While enrolled in this study, all study-related medical care, study drug, and laboratory work, will be provided at no financial cost to the participant.
Your next step:
Seize this opportunity to learn more about the options that are available to you through the ADVANCE-PD Study.
For additional information regarding the ADVANCE-PD Study and to find a study site near you click here.
